Rezolute: Clinical Trials

2 trials sponsored by Rezolute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Rezolute: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
Experimental: Group 1 - 50mg RZ402, Experimental: Group 2 - 200mg RZ402, Experimental: Group 3 - 400mg RZ402 - Diabetic Macular Edema
Phase 2CompletedRezolute942023-02-062026-09-01
An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism
RZ358 Sequential Group Cohort 1, RZ358 Sequential Group Cohort 2, RZ358 Sequential Group Cohort 3 - Congenital Hyperinsulinism
Phase 2CompletedRezolute232020-02-242025-05-28

Conditions studied

Congenital Hyperinsulinism (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Retinopathy (1)  ·  Digestive System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Hypoglycemia (1)  ·  Metabolic Diseases (1)  ·  Pancreatic Diseases (1)

Countries

United States (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  Denmark (1)  ·  Georgia (1)  ·  Germany (1)  ·  Israel (1)  ·  Russia (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Results publications

PMID 40107271